GSk Investigational Site

Brockton, Massachusetts 2301

0 studies enrolling now · 9 studies all time

What they study most

Atherosclerosis, Bowel Dysfunction, Constipation, Depressive Disorder, Major, Hepatitis C, Chronic, Migraine Disorders, Migraine, Acute, Pulmonary Disease, Chronic Obstructive, Rhinitis, Allergic, Perennial

Studies at this site

• A Study to Evaluate Annual Rate of Exacerbations and Safety of 3 Dosage Strengths of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD) — Completed
• Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease — Completed
• Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain — Completed
• Dose Ranging of GSK2336805 in Combination Therapy — Completed
• An Imaging Study in Patients With Atherosclerosis Taking Rilapladib or Placebo for 12 Weeks — Completed
• Seasonal Allergic Rhinitis In Pediatric Subjects — Completed
• Alvimopan For The Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain — Completed
• An 8 Week Study Of Depression In Adults Diagnosed With Major Depressive Disorder — Completed
• TREXIMET® Versus Butalbital-containing Combination Medications for the Acute Treatment of Migraine in Adults — Completed